Related Experiment Videos
Plant polyphenols: biologically active compounds or non-selective binders to protein?
M Zhu1, J D Phillipson, P M Greengrass
1Department of Pharmacy, Chinese University of Hong Kong, NT, Hong Kong.
Phytochemistry
|February 1, 1997
Summary
Phenolic compounds, including proanthocyanidins and gallic acid esters, were tested against 16 receptors. Some compounds selectively inhibited beta-adrenergic, 5HT1, and opiate receptors, suggesting tannins in plant extracts may possess specific biological activity.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Biochemistry
Background:
- Phenolic compounds are abundant in plants and possess diverse biological activities.
- Tannins, a class of phenolic compounds, are often removed from plant extracts during screening.
- The interaction of tannins with biological targets like receptors is not fully understood.
Purpose of the Study:
- To investigate the inhibitory effects of specific phenolic compounds on radioligand binding to various receptors.
- To determine if phenolic compounds exhibit selectivity for certain receptor subtypes.
- To assess the implications of these findings for the screening of plant-derived compounds.
Main Methods:
- Twenty phenolic compounds, including proanthocyanidins and gallic acid/hexahydroxyldiphenic acid esters of glucose, were synthesized or isolated.
- Radioligand binding assays were performed using 16 different receptor targets.
- Inhibition of specific radioligand binding was quantified for each phenolic compound and receptor.
Main Results:
- Phenolic compounds showed no inhibition of ligand binding to 10 out of 16 tested receptors.
- Beta-adrenergic, 5HT1, and opiate receptors were the most susceptible to inhibition by these phenolic compounds.
- Some compounds demonstrated selectivity, inhibiting binding to only one or two specific receptors.
- The observed inhibition could not be solely attributed to general phenolic-protein interactions.
Conclusions:
- Phenolic compounds, particularly tannins, can interact with specific receptor targets.
- Selective receptor binding by phenolic compounds suggests potential therapeutic applications.
- Removing tannins from plant extracts before screening may lead to the loss of valuable biologically active compounds with specific actions.